Novozymes A/S Company Profile (OTCMKTS:NVZMY)

Analyst Ratings

Consensus Ratings for Novozymes A/S (OTCMKTS:NVZMY) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Novozymes A/S (OTCMKTS:NVZMY)
Show:
DateFirmActionRatingPrice TargetActions
1/20/2016Goldman Sachs Group Inc.UpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Nordea Equity ResearchDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/16/2015DanskeDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2014 forward)

Earnings

Earnings History for Novozymes A/S (OTCMKTS:NVZMY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
10/22/2015$0.36$0.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015$0.35$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2015$0.33$0.33ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/20/2015$0.23$0.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014$0.35$0.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/15/2014$0.38$0.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/20/2014$0.33$0.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Novozymes A/S (OTCMKTS:NVZMY)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Novozymes A/S (OTCMKTS:NVZMY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Novozymes A/S (OTCMKTS:NVZMY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Novozymes A/S (OTCMKTS:NVZMY)
DateHeadline
06/30/16 11:25 AMETF’s with exposure to Novozymes A/S : June 30, 2016 -
06/03/16 10:29 AMNovozymes A/S :NVZMY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 -
05/26/16 11:44 AMLatest Analyst Ratings For Novozymes A/S - (NVZMY) - Share Trading News - Latest Analyst Ratings For Novozymes A/S - (NVZMY)Share Trading NewsNovozymes A/S – has a 50 day moving average of 47.00 and a 200 day moving average of 45.48. The stock's market capitalization is 14.52B, it has a 52-week low of 37.98 and a 52-week high of 53.21. The share price of the company (NVZMY) was down ...
04/29/16 08:08 AMConsumer Staples Delivered Top-Notch Performance for VGEAX -
03/29/16 10:03 AMETF’s with exposure to Novozymes A/S : March 29, 2016 -
03/28/16 10:46 AMNovozymes A/S :NVZMY-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/21/16 11:29 AMAn Above-Average Year for FHJUX -
02/22/16 06:03 PMThe Fidelity Advisor Europe Fund: An Above-Average Year -
02/05/16 01:43 PMLatest Analysts Reports On Novozymes A/S - (NVZMY) - Risers & Fallers - Latest Analysts Reports On Novozymes A/S - (NVZMY)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Novozymes A/S – (NVZMY). The latest broker reports which have been released state 0 analysts have a rating of “buy”, 0 analysts “outperform”, 2 analysts “hold”, 1 analysts ...
01/30/16 12:44 PMKerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient Market - Seeking Alpha - Kerry Group Plc - The Biggest Fish In The Highly Fragmented Ingredient MarketSeeking AlphaThese big companies are followed by much smaller players - Naturex (France), Novozymes (OTCPK:NVZMY) (OTCPK:NVZMF) (Denmark), Frutarom (OTC:FRUTF) (Israel), Diana Group (France), etc., in the market. I would like to look at the business of Kerry ...
01/28/16 12:57 PMRecent Broker Updates On Novozymes A/S - (NVZMY) - Risers & Fallers - Recent Broker Updates On Novozymes A/S - (NVZMY)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Novozymes A/S – (NVZMY). The latest broker reports which are currently outstanding on Thursday 28th January state 0 analysts have a rating of “strong buy”, 0 analysts “buy ...
01/25/16 03:11 PMHow the Fidelity Advisor Europe Fund Allocated Its Portfolio in 2015 -
01/21/16 11:22 AMNovozymes A/S Earnings Analysis: Q4, 2015 By the Numbers -
01/20/16 07:22 AMNovozymes upgraded by Goldman -
01/19/16 11:34 AMNovozymes profit up; sees moderate growth in 2016 - MarketWatch - Novozymes profit up; sees moderate growth in 2016MarketWatchDenmark's Novozymes A/S NVZMY, -8.92% Tuesday said it expects "moderate organic sales growth" in 2016 as it reported a lower-than-expected net profit for the fourth quarter last year. Novozymes, the world's largest maker of enzymes used in products ...
01/19/16 11:34 AMNovozymes profit up; sees moderate growth in 2016 - Denmark's Novozymes A/S NVZMY, -4.11% Tuesday said it expects "moderate organic sales growth" in 2016 as it reported a lower-than-expected net profit for the fourth quarter last year. Novozymes, the world's largest maker of enzymes used in products ranging ...
01/18/16 06:43 PMAnalysts Bullish on Novozymes A S - ADR (NVZMY) EPS - OctaFinance.com - Analysts Bullish on Novozymes A S - ADR (NVZMY) EPSOctaFinance.comAnalysts await Novozymes A S – ADR (NVZMY) to reports earnings on January, 19. They expect $0.33 earnings per share, up 10.00 % or $0.03 from last year's $0.3 per share. NVZMY's profit will be $89.24 million for 32.55 P/E if the $0.33 EPS becomes ...
12/23/15 04:00 PMA Look at FHJUX’s Portfolio through November 2015 -
10/28/15 01:02 PMThe Fidelity Advisor Europe Fund Class A (FHJUX): Historical Overview -
10/27/15 10:18 AMNovozymes A/S Earnings Q3, 2015 -
10/23/15 01:02 PMNovozymes A/S – Value Analysis (US OTC:NVZMY) : October 23, 2015 -
10/22/15 01:15 AMThere is uncertainty around biofuels: Novzymes CEO -
08/24/15 12:40 PMNovozymes A/S Q2 Earnings Analysis: By the Numbers, 2015 -
08/06/15 01:15 AMNovozyme earnings weaker than expected -
01/20/15 05:24 AMEuropean Stocks Rise on Climb in German Investor Confidence -
07/26/14 09:36 AMScience on the job: Teachers learn from tech firms -

Social

About Novozymes A/S

Novozymes A/S logoNovozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions. The Food & Beverages (old Food & Beverages Enzymes) manufactures enzymes for the food industry. The Bioenergy (old Bioenergy Enzymes) provides enzymes to the energy industry. The Agriculture & Feed area combines old Feed & Other Technical Enzymes area (enzymes sales to the feed industry) and microorganism sales for aquaculture and agriculture. The Technical & Pharma area combines old Feed & Other Technical Enzymes area (enzymes to other technical industries), microorganism sales for wastewater treatment, and Biopharma (recombinant ingredients and technologies).

Industry, Sector and Symbol:
  • Sector: Basic Materials
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: NVZMY
  • CUSIP:
Key Metrics:
  • Previous Close: $49.25
  • 50 Day Moving Average: $47.42
  • 200 Day Moving Average: $45.49
  • P/E Ratio: 35.92
  • P/E Growth: 3.94
  • Market Cap: $14.89B
  • Beta: 0.75
  • Current Year EPS Consensus Estimate: $1.52 EPS
  • Next Year EPS Consensus Estimate: $1.64 EPS
Additional Links:
Novozymes A/S (OTCMKTS:NVZMY) Chart for Saturday, July, 30, 2016